APPB (Applied Biosciences) Total Liabilities: $2.28 Mil (As of Dec. 2019)


APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences Total Liabilities?

Applied Biosciences APPB 12 Total Liabilities is $2.28 Mil as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's Total Liabilities for the quarter that ended in Dec. 2019 was $2.28 Mil.

Applied Biosciences's quarterly Total Liabilities increased from Jun. 2019 ($0.68 Mil) to Sep. 2019 ($1.32 Mil) and increased from Sep. 2019 ($1.32 Mil) to Dec. 2019 ($2.28 Mil).

Applied Biosciences's annual Total Liabilities increased from Mar. 2016 ($0.01 Mil) to Mar. 2017 ($0.03 Mil) and increased from Mar. 2017 ($0.03 Mil) to Mar. 2018 ($0.04 Mil).


Applied Biosciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Total Liabilities Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Total Liabilities
0.00 0.01 0.01 0.03 0.04

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.37 0.68 1.32 2.28
APPB
12GF Score
Applied Biosciences Corp APPB
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Applied Biosciences's Total Liabilities for the fiscal year that ended in Mar. 2018 is calculated as

Total Liabilities=Total Assets (A: Mar. 2018 )-Total Equity (A: Mar. 2018 )
=0.705-0.669
=0.04

Applied Biosciences's Total Liabilities for the quarter that ended in Dec. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.019+(0.262+-0.0010000000000003
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.28

Total Liabilities=Total Assets (Q: Dec. 2019 )-Total Equity (Q: Dec. 2019 )
=3.418-1.138
=2.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2.28 Mil mean?
Applied Biosciences (APPB) has a Total Liabilities of $2.28 Mil as of Dec. 2019. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Applied Biosciences and its competitors.
Is Applied Biosciences' Total Liabilities too high?
Applied Biosciences' current Total Liabilities is $2.28 Mil. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' Total Liabilities compare to CNABQ and OWCP?
Applied Biosciences' Total Liabilities of $2.28 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Applied Biosciences and its competitors. Applied Biosciences's current Total Liabilities is $2.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current Total Liabilities of $2.28 Mil. The current Total Liabilities is $2.28 Mil. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Applied Biosciences (APPB), the current Total Liabilities is $2.28 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price